Bigitace Pharma Private Limited
About Bigitace Pharma Private Limited
Data last updated:
Bigitace Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24290MH2020PTC349926.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rupesh Dipakrao Thakare and Suraj Niranjan Landage.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gokul Appartment No A02, 307 Third Floor Near Nci Hospital Vrindavan City Jamtha Nagpur, Maharashtra, India – 440023.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGokul Appartment No A02, 307 Third Floor Near Nci Hospital Vrindavan City Jamtha Nagpur, Maharashtra, India – 440023
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Bigitace Pharma Private Limited FY 2025 filings available
Financial Statement Summary of Bigitace Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bigitace Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bigitace Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Bigitace Pharma Private Limited
Bigitace Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupesh Dipakrao Thakare | Director | 11 Nov 2020 | 5 Years 11 Months | Current |
| Suraj Niranjan Landage | Director | 11 Nov 2020 | 5 Years 11 Months | Current |
| Shailesh Pralhadrao Khadse | Director | 11 Nov 2020 | 5 Years 11 Months | Current |
Charges & Borrowings of Bigitace Pharma Private Limited
Bigitace Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bigitace Pharma Private Limited
Employment history and EPFO contributions of people linked to Bigitace Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bigitace Pharma Private Limited
Bigitace Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Rupesh Dipakrao Thakare was appointed as Director on 11 Nov 2020.
Credit Ratings, Litigation & Regulatory Alerts for Bigitace Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bigitace Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bigitace Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bigitace Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bigitace Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bigitace Pharma Private Limited
Bigitace Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 November 2020 (6+ years old) and is registered under CIN U24290MH2020PTC349926.
Bigitace Pharma has 3 current directors:
- Rupesh Dipakrao Thakare - Director
- Suraj Niranjan Landage - Director
- Shailesh Pralhadrao Khadse - Director
The CIN (Corporate Identification Number) of Bigitace Pharma is U24290MH2020PTC349926. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bigitace Pharma was incorporated on 11 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Nagpur.
Rupesh Dipakrao Thakare was appointed as Director on 11 Nov 2020. Shailesh Pralhadrao Khadse was appointed as Director on 11 Nov 2020. Suraj Niranjan Landage was appointed as Director on 11 Nov 2020.
The registered office of Bigitace Pharma is at Gokul Appartment No A02, 307 Third Floor Near Nci Hospital Vrindavan City Jamtha Nagpur, Maharashtra, India – 440023.
Bigitace Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.
Bigitace Pharma operates in the chemicals industry, in the manufacturing segment.
No. Bigitace Pharma is not listed on any stock exchange. It is an unlisted company.
The compliance status of Bigitace Pharma is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.